Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Antiplatelet Agents for Prevention of Thromboembolism in Atrial Fibrillation: When, Why, and Which One?

    Atrial fibrillation (AF) carries a high risk of systemic embolism, in particular stroke. This is true not only when AF is associated with valvular heart disease, but also in patients with nonvalvular AF, which...

    G. Di Pasquale, E. Cerè, S. Biancoli, B. Sassone, A. Lombardi in Cardiac Arrhythmias 2001 (2002)